GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM30949
Query DataSets for GSM30949
Status
Public on Jul 20, 2005
Title
WM793-P2N1-treated
Sample type
RNA
Source name
WM793-P2N1
Organism
Homo sapiens
Extracted molecule
total RNA
Description
Melanoma cell line WM793-P2N1 treated with 2ug/ml DAC as per publication
Submission date
Sep 22, 2004
Last update date
Jul 20, 2005
Contact name
Edward Fox
E-mail(s)
edward.fox@ucd.ie
Phone
+353 1 716 6846
Organization name
Conway Institute
Department
Street address
City
Dublin
ZIP/Postal code
4
Country
Ireland
Platform ID
GPL80
Series (1)
GSE1793
Melanoma progression model:DAC-mediated gene expression
Data table header descriptions
ID_REF
VALUE
signal' a measure of the abundance of a transcript
ABS_CALL
The call in an absolute analysis that indicates if the transcript was present (P), absent (A), marginal (M), or no call (NC)
DETECTION P-VALUE
detection p-value', p-value that indicates the significance level of the detection call
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-BioB-5_at
20.8
A
0.062929
AFFX-BioB-M_at
32.3
P
0.010317
AFFX-BioB-3_at
19.7
P
0.021902
AFFX-BioC-5_at
53.5
P
0.000972
AFFX-BioC-3_at
33
P
0.00039
AFFX-BioDn-5_at
33.5
P
0.00141
AFFX-BioDn-3_at
301.3
P
0.000195
AFFX-CreX-5_at
450.2
P
0.000044
AFFX-CreX-3_at
715.5
P
0.000044
AFFX-BioB-5_st
4
A
0.440646
AFFX-BioB-M_st
1.5
A
0.824693
AFFX-BioB-3_st
2.3
A
0.783476
AFFX-BioC-5_st
0.8
A
0.883887
AFFX-BioC-3_st
1.2
A
0.749204
AFFX-BioDn-5_st
7
A
0.165861
AFFX-BioDn-3_st
8.5
A
0.327079
AFFX-CreX-5_st
7.6
A
0.13134
AFFX-CreX-3_st
9.1
A
0.250796
hum_alu_at
2713
P
0
AFFX-DapX-5_at
0.7
A
0.804734
Total number of rows:
7129
Table truncated, full table size
184 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|